论文部分内容阅读
目的 :探讨肝癌病理类型与血清总补体 (CH5 0 )水平的关系。方法 :测定 46例原发性肝细胞癌患者的血清 CH5 0 水平 ,并根据不同病理类型进行分类比较。结果 :巨大肝癌组的血清 CH5 0 水平明显高于大肝癌组和小肝癌组 (P<0 .0 5 ) ;高分化肝癌组的血清 CH5 0 水平明显高于中分化肝癌组和低分化肝癌组 (P<0 .0 5 )。结论 :肝癌患者的血清 CH5 0 水平高低可能与肝癌大小、肝癌的分化程度有关。
Objective: To investigate the relationship between pathological types of hepatocellular carcinoma and serum total complement (CH50) levels. Methods: Serum levels of CH5 0 in 46 patients with primary hepatocellular carcinoma were determined and classified according to different pathological types. Results: Serum levels of CH5 0 were significantly higher in HCC than those in HCC and HCC (P <0.05). Serum levels of CH5 0 in HCC were significantly higher than those in moderately differentiated and poorly differentiated HCC (P <0. 05). Conclusion: The level of serum CH5 0 in patients with liver cancer may be related to the size of liver cancer and the degree of differentiation of liver cancer.